ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025

Core Viewpoint - ImmuCell Corporation is set to report its unaudited financial results for Q2 2025 on August 14, 2025, with a conference call scheduled for the following morning to discuss these results [1][2][3]. Financial Results - The company anticipates no changes to the preliminary sales results for the second quarter ended June 30, 2025, which were previously disclosed on July 9, 2025 [3]. Conference Call Details - A conference call will be held on August 15, 2025, at 9:00 AM ET, accessible via specific toll-free and international numbers [2]. - A replay of the conference call will be available until August 22, 2025, with designated access codes for listeners [2]. Corporate Presentation - Investors are encouraged to review the updated Corporate Presentation slide deck available on the company's website, which will be updated after the market closes on August 14, 2025 [4]. Company Overview - ImmuCell Corporation focuses on developing products that enhance the health and productivity of dairy and beef cattle, including First Defense for newborn calves and Re-Tain for treating subclinical mastitis in dairy cows [5].